People | April 29, 2026
NADMED Limited appoints James Lee as CEO to drive global expansion
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Sevabertinib is an oral, reversible tyrosine kinase inhibitor (TKI) that directly targets HER2 mutations
ekincare has raised a total funding of $22M since 2015 till date
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
Services like 24/7 Ayush Multi-OPD clinics, mobile healthcare units, free distribution of Ayush medicines, and yoga camps are there for all visitors
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Objective tracking data combined with cohort data to drive medicine of the future
Subscribe To Our Newsletter & Stay Updated
